News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Delticom publishes Annual Report 2024: Operating EBITDA increased to € 22.7 million, dividend proposal of € 0.12 per share
Delticom AG's Annual Report 2024 reveals increased Operating EBITDA to €22.7 million and proposes a dividend of €0.12 per share. Find detailed financial figures and outlook in the report -
COMMUNIQUÉ DE PRESSE
Revised nomination proposal by the Supervisory Board for the Supervisory Board elections at the Annual General Meeting on 1 April 2025
Deutsche Konsum REIT-AG revises nomination proposal for Supervisory Board elections at 2025 AGM, introduces new candidates to ensure independence -
-
-
-
COMMUNIQUÉ DE PRESSE
GBC AG Initiates Coverage on Marinomed Biotech AG – Buy Recommendation with Price Target of EUR 42.00
GBC AG initiates coverage on Marinomed Biotech AG with a Buy recommendation and EUR 42.00 price target. Focus on innovative Marinosolv® technology for immunological and inflammatory diseases -
COMMUNIQUÉ DE PRESSE
Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Napo Pharmaceuticals presents statistically significant responder analysis results for crofelemer in breast cancer patients at San Antonio Breast Cancer Symposium and MASCC, FDA Type C Meeting scheduled for 2025
